REIT - Residential
Compare Stocks
2 / 10Stock Comparison
ELS vs NUVB
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
ELS vs NUVB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Residential | Biotechnology |
| Market Cap | $12.28B | $1.75B |
| Revenue (TTM) | $1.53B | $143M |
| Net Income (TTM) | $387M | $-146M |
| Gross Margin | 37.6% | 91.6% |
| Operating Margin | 33.8% | -105.0% |
| Forward P/E | 31.1x | — |
| Total Debt | $3.37B | $10M |
| Cash & Equiv. | $26M | $164M |
ELS vs NUVB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 20 | May 26 | Return |
|---|---|---|---|
| Equity LifeStyle Pr… (ELS) | 100 | 95.5 | -4.5% |
| Nuvation Bio Inc. (NUVB) | 100 | 50.4 | -49.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ELS vs NUVB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ELS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.02, yield 3.2%
- 112.2% 10Y total return vs NUVB's -49.6%
- Lower volatility, beta 0.02, current ratio 1.68x
NUVB is the clearest fit if your priority is growth exposure.
- Rev growth 7.0%, EPS growth 71.6%
- 7.0% revenue growth vs ELS's 6.8%
- +141.1% vs ELS's +2.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.0% revenue growth vs ELS's 6.8% | |
| Quality / Margins | 25.2% margin vs NUVB's -102.1% | |
| Stability / Safety | Beta 0.02 vs NUVB's 2.04 | |
| Dividends | 3.2% yield; 12-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +141.1% vs ELS's +2.6% | |
| Efficiency (ROA) | 6.8% ROA vs NUVB's -23.8%, ROIC 7.6% vs -54.3% |
ELS vs NUVB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ELS vs NUVB — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — ELS and NUVB each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ELS is the larger business by revenue, generating $1.5B annually — 10.7x NUVB's $143M. ELS is the more profitable business, keeping 25.2% of every revenue dollar as net income compared to NUVB's -102.1%. On growth, NUVB holds the edge at +26.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.5B | $143M |
| EBITDAEarnings before interest/tax | $727M | -$145M |
| Net IncomeAfter-tax profit | $387M | -$146M |
| Free Cash FlowCash after capex | $334M | -$126M |
| Gross MarginGross profit ÷ Revenue | +37.6% | +91.6% |
| Operating MarginEBIT ÷ Revenue | +33.8% | -105.0% |
| Net MarginNet income ÷ Revenue | +25.2% | -102.1% |
| FCF MarginFCF ÷ Revenue | +21.8% | -88.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +22.4% | +26.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -8.3% | +106.3% |
Valuation Metrics
NUVB leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $12.3B | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $15.6B | $1.6B |
| Trailing P/EPrice ÷ TTM EPS | 32.81x | -8.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.12x | — |
| PEG RatioP/E ÷ EPS growth rate | 3.17x | — |
| EV / EBITDAEnterprise value multiple | 21.49x | — |
| Price / SalesMarket cap ÷ Revenue | 8.02x | 27.82x |
| Price / BookPrice ÷ Book value/share | 6.98x | 5.63x |
| Price / FCFMarket cap ÷ FCF | 36.76x | — |
Profitability & Efficiency
ELS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ELS delivers a 21.3% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-44 for NUVB. NUVB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ELS's 1.85x. On the Piotroski fundamental quality scale (0–9), ELS scores 6/9 vs NUVB's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +21.3% | -44.1% |
| ROA (TTM)Return on assets | +6.8% | -23.8% |
| ROICReturn on invested capital | +7.6% | -54.3% |
| ROCEReturn on capital employed | +9.7% | -42.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 1.85x | 0.03x |
| Net DebtTotal debt minus cash | $3.3B | -$154M |
| Cash & Equiv.Liquid assets | $26M | $164M |
| Total DebtShort + long-term debt | $3.4B | $10M |
| Interest CoverageEBIT ÷ Interest expense | 2.98x | -162.11x |
Total Returns (Dividends Reinvested)
Evenly matched — ELS and NUVB each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ELS five years ago would be worth $10,412 today (with dividends reinvested), compared to $4,574 for NUVB. Over the past 12 months, NUVB leads with a +141.1% total return vs ELS's +2.6%. The 3-year compound annual growth rate (CAGR) favors NUVB at 46.0% vs ELS's 0.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +6.8% | -41.3% |
| 1-Year ReturnPast 12 months | +2.6% | +141.1% |
| 3-Year ReturnCumulative with dividends | +0.2% | +211.1% |
| 5-Year ReturnCumulative with dividends | +4.1% | -54.3% |
| 10-Year ReturnCumulative with dividends | +112.2% | -49.6% |
| CAGR (3Y)Annualised 3-year return | +0.1% | +46.0% |
Risk & Volatility
ELS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ELS is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than NUVB's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ELS currently trades 91.8% from its 52-week high vs NUVB's 51.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.02x | 2.04x |
| 52-Week HighHighest price in past year | $69.00 | $9.75 |
| 52-Week LowLowest price in past year | $58.15 | $1.57 |
| % of 52W HighCurrent price vs 52-week peak | +91.8% | +51.7% |
| RSI (14)Momentum oscillator 0–100 | 41.0 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 1.7M | 4.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ELS as "Buy" and NUVB as "Buy". Consensus price targets imply 146.0% upside for NUVB (target: $12) vs 11.4% for ELS (target: $71). ELS is the only dividend payer here at 3.20% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $70.57 | $12.40 |
| # AnalystsCovering analysts | 21 | 9 |
| Dividend YieldAnnual dividend ÷ price | +3.2% | — |
| Dividend StreakConsecutive years of raises | 12 | — |
| Dividend / ShareAnnual DPS | $2.02 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
ELS leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). NUVB leads in 1 (Valuation Metrics). 2 tied.
ELS vs NUVB: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ELS or NUVB a better buy right now?
For growth investors, Nuvation Bio Inc.
(NUVB) is the stronger pick with 699. 0% revenue growth year-over-year, versus 6. 8% for Equity LifeStyle Properties, Inc. (ELS). Equity LifeStyle Properties, Inc. (ELS) offers the better valuation at 32. 8x trailing P/E (31. 1x forward), making it the more compelling value choice. Analysts rate Equity LifeStyle Properties, Inc. (ELS) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ELS or NUVB?
Over the past 5 years, Equity LifeStyle Properties, Inc.
(ELS) delivered a total return of +4. 1%, compared to -54. 3% for Nuvation Bio Inc. (NUVB). Over 10 years, the gap is even starker: ELS returned +112. 2% versus NUVB's -49. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ELS or NUVB?
By beta (market sensitivity over 5 years), Equity LifeStyle Properties, Inc.
(ELS) is the lower-risk stock at 0. 02β versus Nuvation Bio Inc. 's 2. 04β — meaning NUVB is approximately 9648% more volatile than ELS relative to the S&P 500. On balance sheet safety, Nuvation Bio Inc. (NUVB) carries a lower debt/equity ratio of 3% versus 185% for Equity LifeStyle Properties, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ELS or NUVB?
By revenue growth (latest reported year), Nuvation Bio Inc.
(NUVB) is pulling ahead at 699. 0% versus 6. 8% for Equity LifeStyle Properties, Inc. (ELS). On earnings-per-share growth, the picture is similar: Nuvation Bio Inc. grew EPS 71. 6% year-over-year, compared to -1. 5% for Equity LifeStyle Properties, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ELS or NUVB?
Equity LifeStyle Properties, Inc.
(ELS) is the more profitable company, earning 25. 2% net margin versus -325. 3% for Nuvation Bio Inc. — meaning it keeps 25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELS leads at 33. 8% versus -338. 7% for NUVB. At the gross margin level — before operating expenses — NUVB leads at 86. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ELS or NUVB more undervalued right now?
Analyst consensus price targets imply the most upside for NUVB: 146.
0% to $12. 40.
07Which pays a better dividend — ELS or NUVB?
In this comparison, ELS (3.
2% yield) pays a dividend. NUVB does not pay a meaningful dividend and should not be held primarily for income.
08Is ELS or NUVB better for a retirement portfolio?
For long-horizon retirement investors, Equity LifeStyle Properties, Inc.
(ELS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 02), 3. 2% yield, +112. 2% 10Y return). Nuvation Bio Inc. (NUVB) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ELS: +112. 2%, NUVB: -49. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ELS and NUVB?
These companies operate in different sectors (ELS (Real Estate) and NUVB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ELS is a mid-cap income-oriented stock; NUVB is a small-cap high-growth stock. ELS pays a dividend while NUVB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.